Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0268318 (
ICP
)
10,007
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Aquaporin-4
(
AQP4
) is the major water channel in the brain, expressed predominantly in astroglial cell membranes. Initial studies in
AQP4
-deficient mice showed reduced cellular brain edema following water intoxication and ischemic stroke. We hypothesized that
AQP4
deletion would have the opposite effect (increased brain swelling) in vasogenic (noncellular) edema because of impaired removal of excess brain water through glial limitans and ependymal barriers. In support of this hypothesis, we found higher intracranial pressure (
ICP
, 52+/-6 vs. 26+/-3 cm H2O) and brain water content (81.2+/-0.1 vs. 80.4+/-0.1%) in
AQP4
-deficient mice after continuous intraparenchymal fluid infusion. In a freeze-injury model of vasogenic brain edema,
AQP4
-deficient mice had remarkably worse clinical outcome, higher
ICP
(22+/-4 vs. 9+/-1 cm H2O), and greater brain water content (80.9+/-0.1 vs. 79.4+/-0.1%). In a brain tumor edema model involving stereotactic implantation of melanoma cells, tumor growth was comparable in wild-type and
AQP4
-deficient mice. However,
AQP4
-deficient mice had higher
ICP
(39+/-4 vs. 19+/-5 cm H2O at seven days postimplantation) and corresponding accelerated neurological deterioration. Thus,
AQP4
-mediated transcellular water movement is crucial for fluid clearance in vasogenic brain edema, suggesting
AQP4
activation and/or up-regulation as a novel therapeutic option in vasogenic brain edema.
...
PMID:Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. 1520 68